| Symbol | AIMV |
|---|---|
| Name | AI MAVERICK INTEL, INC. |
| Sector | TECHNOLOGY |
| Region | North America |
| Industry | - |
| Address | L5M 5R3 Canada ON 5480 Glen Erin Drive - Unit 105 |
| Telephone | +1 905-505-0770 |
| Fax | — |
| — | |
| Website | https://aimaverickintel.com/ |
| Incorporation | US |
| Incorporated On | 2006 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Aloba, Awomolo & Partners; |
| Audit Status | AUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001368286 |
| Description | Bionoid Pharma Inc. is a forward-thinking company focused on leveraging artificial intelligence to unlock new commercial opportunities and improve digital engagement. With a strategic emphasis on growth through acquisitions, Bionoids five-year roadmap includes acquiring revenue-generating businesses and integrating its proprietary AI Maverick technology to enhance operational efficiency and user experience. AI Maverick is a versatile, AI-powered platform designed to support a wide range of applications, from intelligent customer interaction tools to dynamic communication and data-driven engagement systems. As Bionoid continues to evolve, the flexibility of the Maverick platform provides a foundation for innovation across multiple sectors. Through these initiatives, the company aims to build long-term value, attract strategic partners, and establish a strong position in the rapidly expanding AI ecosystem. Additional info from OTC: Additional info from NASDAQ: |
No news found.